Click for best price
Autoimmune Disorder Drug Delivery Device Market Size, Share 2023
The exponential rise in the adoption of self-injection devices for the treatment of autoimmune disorders has created a buzz among companies to invest in the development of novel autoimmune disorder drug delivery devices. Due to the leading market products and intense market penetration, Amgen Inc. has been a pioneer in this field and has been a significant competitor in this market.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disorder Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disorder Drug Delivery Device. This report contains market size and forecasts of Autoimmune Disorder Drug Delivery Device in global, including the following market information:
Global Autoimmune Disorder Drug Delivery Device Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Autoimmune Disorder Drug Delivery Device Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Autoimmune Disorder Drug Delivery Device companies in 2022 (%)
The global Autoimmune Disorder Drug Delivery Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Pen Injectors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Autoimmune Disorder Drug Delivery Device include AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Biogen Inc., Merck KGaA, Bayer AG and Johnson & Johnson Services Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Autoimmune Disorder Drug Delivery Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Autoimmune Disorder Drug Delivery Device Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Autoimmune Disorder Drug Delivery Device Market Segment Percentages, by Type, 2022 (%)
Pen Injectors
Auto-Injectors
Prefilled Syringes
Vials
Global Autoimmune Disorder Drug Delivery Device Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Autoimmune Disorder Drug Delivery Device Market Segment Percentages, by Application, 2022 (%)
In-house Manufacturing
Outsourced Manufacturing
Global Autoimmune Disorder Drug Delivery Device Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Autoimmune Disorder Drug Delivery Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Autoimmune Disorder Drug Delivery Device revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Autoimmune Disorder Drug Delivery Device revenues share in global market, 2022 (%)
Key companies Autoimmune Disorder Drug Delivery Device sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Autoimmune Disorder Drug Delivery Device sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc.
Amgen Inc.
F. Hoffmann- La Roche Ltd.
Novartis AG
GlaxoSmithKline Plc
Biogen Inc.
Merck KGaA
Bayer AG
Johnson & Johnson Services Inc.
Teva Pharmaceutical Industries Ltd.
Eli Lily and Company
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Autoimmune Disorder Drug Delivery Device, market overview.
Chapter 2: Global Autoimmune Disorder Drug Delivery Device market size in revenue and volume.
Chapter 3: Detailed analysis of Autoimmune Disorder Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Autoimmune Disorder Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Autoimmune Disorder Drug Delivery Device capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Autoimmune Disorder Drug Delivery Device Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
73 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Autoimmune Disorder Drug Delivery Device Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Autoimmune Disorder Drug Delivery Device Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Autoimmune Disorder Drug Delivery Device Overall Market Size
2.1 Global Autoimmune Disorder Drug Delivery Device Market Size: 2022 VS 2030
2.2 Global Autoimmune Disorder Drug Delivery Device Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Autoimmune Disorder Drug Delivery Device Sales: 2018-2030
3 Company Landscape
3.1 Top Autoimmune Disorder Drug Delivery Device Players in Global Market
3.2 Top Global Autoimmune Disorder Drug Delivery Device Companies Ranked by Revenue
3.3 Global Autoimmune Disorder Drug Delivery Device Revenue by Companies
3.4 Global Autoimmune Disorder Drug Delivery Device Sales by Companies
3.5 Global Autoimmune Disorder Drug Delivery Device Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Autoimmune Disorder Drug Delivery Device Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Autoimmune Disorder Drug Delivery Device Product Type
3.8 Tier 1, Tier 2 and Tier 3 Autoimmune Disorder Drug Delivery Device Players in Global Market
3.8.1 List of Global Tier 1 Autoimmune Disorder Drug Delivery Device Companies
3.8.2 List of Global Tier 2 and Tier 3 Autoimmune Disorder Drug Delivery Device Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Autoimmune Disorder Drug Delivery Device Market Size Markets, 2022 & 2030
4.1.2 Pen Injectors
4.1.3 Auto-Injectors
4.1.4 Prefilled Syringes
4.1.5 Vials
4.2 By Type - Global Autoimmune Disorder Drug Delivery Device Revenue & Forecasts
4.2.1 By Type - Global Autoimmune Disorder Drug Delivery Device Revenue, 2018-2023
4.2.2 By Type - Global Autoimmune Disorder Drug Delivery Device Revenue, 2024-2030
4.2.3 By Type - Global Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
4.3 By Type - Global Autoimmune Disorder Drug Delivery Device Sales & Forecasts
4.3.1 By Type - Global Autoimmune Disorder Drug Delivery Device Sales, 2018-2023
4.3.2 By Type - Global Autoimmune Disorder Drug Delivery Device Sales, 2024-2030
4.3.3 By Type - Global Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
4.4 By Type - Global Autoimmune Disorder Drug Delivery Device Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Autoimmune Disorder Drug Delivery Device Market Size, 2022 & 2030
5.1.2 In-house Manufacturing
5.1.3 Outsourced Manufacturing
5.2 By Application - Global Autoimmune Disorder Drug Delivery Device Revenue & Forecasts
5.2.1 By Application - Global Autoimmune Disorder Drug Delivery Device Revenue, 2018-2023
5.2.2 By Application - Global Autoimmune Disorder Drug Delivery Device Revenue, 2024-2030
5.2.3 By Application - Global Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
5.3 By Application - Global Autoimmune Disorder Drug Delivery Device Sales & Forecasts
5.3.1 By Application - Global Autoimmune Disorder Drug Delivery Device Sales, 2018-2023
5.3.2 By Application - Global Autoimmune Disorder Drug Delivery Device Sales, 2024-2030
5.3.3 By Application - Global Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
5.4 By Application - Global Autoimmune Disorder Drug Delivery Device Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Autoimmune Disorder Drug Delivery Device Market Size, 2022 & 2030
6.2 By Region - Global Autoimmune Disorder Drug Delivery Device Revenue & Forecasts
6.2.1 By Region - Global Autoimmune Disorder Drug Delivery Device Revenue, 2018-2023
6.2.2 By Region - Global Autoimmune Disorder Drug Delivery Device Revenue, 2024-2030
6.2.3 By Region - Global Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
6.3 By Region - Global Autoimmune Disorder Drug Delivery Device Sales & Forecasts
6.3.1 By Region - Global Autoimmune Disorder Drug Delivery Device Sales, 2018-2023
6.3.2 By Region - Global Autoimmune Disorder Drug Delivery Device Sales, 2024-2030
6.3.3 By Region - Global Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Autoimmune Disorder Drug Delivery Device Revenue, 2018-2030
6.4.2 By Country - North America Autoimmune Disorder Drug Delivery Device Sales, 2018-2030
6.4.3 US Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.4.4 Canada Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.4.5 Mexico Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Autoimmune Disorder Drug Delivery Device Revenue, 2018-2030
6.5.2 By Country - Europe Autoimmune Disorder Drug Delivery Device Sales, 2018-2030
6.5.3 Germany Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.5.4 France Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.5.5 U.K. Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.5.6 Italy Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.5.7 Russia Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.5.8 Nordic Countries Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.5.9 Benelux Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Autoimmune Disorder Drug Delivery Device Revenue, 2018-2030
6.6.2 By Region - Asia Autoimmune Disorder Drug Delivery Device Sales, 2018-2030
6.6.3 China Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.6.4 Japan Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.6.5 South Korea Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.6.6 Southeast Asia Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.6.7 India Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Autoimmune Disorder Drug Delivery Device Revenue, 2018-2030
6.7.2 By Country - South America Autoimmune Disorder Drug Delivery Device Sales, 2018-2030
6.7.3 Brazil Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.7.4 Argentina Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales, 2018-2030
6.8.3 Turkey Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.8.4 Israel Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.8.5 Saudi Arabia Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
6.8.6 UAE Autoimmune Disorder Drug Delivery Device Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Company Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.1.4 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Inc. Key News & Latest Developments
7.2 Amgen Inc.
7.2.1 Amgen Inc. Company Summary
7.2.2 Amgen Inc. Business Overview
7.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.2.4 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Inc. Key News & Latest Developments
7.3 F. Hoffmann- La Roche Ltd.
7.3.1 F. Hoffmann- La Roche Ltd. Company Summary
7.3.2 F. Hoffmann- La Roche Ltd. Business Overview
7.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.3.4 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.3.5 F. Hoffmann- La Roche Ltd. Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.4.4 Novartis AG Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 GlaxoSmithKline Plc
7.5.1 GlaxoSmithKline Plc Company Summary
7.5.2 GlaxoSmithKline Plc Business Overview
7.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.5.4 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Plc Key News & Latest Developments
7.6 Biogen Inc.
7.6.1 Biogen Inc. Company Summary
7.6.2 Biogen Inc. Business Overview
7.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.6.4 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.6.5 Biogen Inc. Key News & Latest Developments
7.7 Merck KGaA
7.7.1 Merck KGaA Company Summary
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.7.4 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.7.5 Merck KGaA Key News & Latest Developments
7.8 Bayer AG
7.8.1 Bayer AG Company Summary
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.8.4 Bayer AG Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.8.5 Bayer AG Key News & Latest Developments
7.9 Johnson & Johnson Services Inc.
7.9.1 Johnson & Johnson Services Inc. Company Summary
7.9.2 Johnson & Johnson Services Inc. Business Overview
7.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.9.4 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.9.5 Johnson & Johnson Services Inc. Key News & Latest Developments
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Company Summary
7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
7.11 Eli Lily and Company
7.11.1 Eli Lily and Company Company Summary
7.11.2 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Business Overview
7.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.11.4 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.11.5 Eli Lily and Company Key News & Latest Developments
7.12 Sanofi S.A.
7.12.1 Sanofi S.A. Company Summary
7.12.2 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Business Overview
7.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.12.4 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.12.5 Sanofi S.A. Key News & Latest Developments
7.13 Takeda Pharmaceutical Company Limited
7.13.1 Takeda Pharmaceutical Company Limited Company Summary
7.13.2 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Business Overview
7.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Major Product Offerings
7.13.4 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales and Revenue in Global (2018-2023)
7.13.5 Takeda Pharmaceutical Company Limited Key News & Latest Developments
8 Global Autoimmune Disorder Drug Delivery Device Production Capacity, Analysis
8.1 Global Autoimmune Disorder Drug Delivery Device Production Capacity, 2018-2030
8.2 Autoimmune Disorder Drug Delivery Device Production Capacity of Key Manufacturers in Global Market
8.3 Global Autoimmune Disorder Drug Delivery Device Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Autoimmune Disorder Drug Delivery Device Supply Chain Analysis
10.1 Autoimmune Disorder Drug Delivery Device Industry Value Chain
10.2 Autoimmune Disorder Drug Delivery Device Upstream Market
10.3 Autoimmune Disorder Drug Delivery Device Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Autoimmune Disorder Drug Delivery Device Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Autoimmune Disorder Drug Delivery Device in Global Market
Table 2. Top Autoimmune Disorder Drug Delivery Device Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Autoimmune Disorder Drug Delivery Device Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Autoimmune Disorder Drug Delivery Device Revenue Share by Companies, 2018-2023
Table 5. Global Autoimmune Disorder Drug Delivery Device Sales by Companies, (K Units), 2018-2023
Table 6. Global Autoimmune Disorder Drug Delivery Device Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Autoimmune Disorder Drug Delivery Device Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Autoimmune Disorder Drug Delivery Device Product Type
Table 9. List of Global Tier 1 Autoimmune Disorder Drug Delivery Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Autoimmune Disorder Drug Delivery Device Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Autoimmune Disorder Drug Delivery Device Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Autoimmune Disorder Drug Delivery Device Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Autoimmune Disorder Drug Delivery Device Sales (K Units), 2018-2023
Table 15. By Type - Global Autoimmune Disorder Drug Delivery Device Sales (K Units), 2024-2030
Table 16. By Application ? Global Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Autoimmune Disorder Drug Delivery Device Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Autoimmune Disorder Drug Delivery Device Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Autoimmune Disorder Drug Delivery Device Sales (K Units), 2018-2023
Table 20. By Application - Global Autoimmune Disorder Drug Delivery Device Sales (K Units), 2024-2030
Table 21. By Region ? Global Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Autoimmune Disorder Drug Delivery Device Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Autoimmune Disorder Drug Delivery Device Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Autoimmune Disorder Drug Delivery Device Sales (K Units), 2018-2023
Table 25. By Region - Global Autoimmune Disorder Drug Delivery Device Sales (K Units), 2024-2030
Table 26. By Country - North America Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2018-2023
Table 29. By Country - North America Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2024-2030
Table 30. By Country - Europe Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2018-2023
Table 33. By Country - Europe Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2024-2030
Table 34. By Region - Asia Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2018-2023
Table 37. By Region - Asia Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2024-2030
Table 38. By Country - South America Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2018-2023
Table 41. By Country - South America Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales, (K Units), 2024-2030
Table 46. AbbVie Inc. Company Summary
Table 47. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Product Offerings
Table 48. AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AbbVie Inc. Key News & Latest Developments
Table 50. Amgen Inc. Company Summary
Table 51. Amgen Inc. Autoimmune Disorder Drug Delivery Device Product Offerings
Table 52. Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Amgen Inc. Key News & Latest Developments
Table 54. F. Hoffmann- La Roche Ltd. Company Summary
Table 55. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Product Offerings
Table 56. F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. F. Hoffmann- La Roche Ltd. Key News & Latest Developments
Table 58. Novartis AG Company Summary
Table 59. Novartis AG Autoimmune Disorder Drug Delivery Device Product Offerings
Table 60. Novartis AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Novartis AG Key News & Latest Developments
Table 62. GlaxoSmithKline Plc Company Summary
Table 63. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Product Offerings
Table 64. GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. GlaxoSmithKline Plc Key News & Latest Developments
Table 66. Biogen Inc. Company Summary
Table 67. Biogen Inc. Autoimmune Disorder Drug Delivery Device Product Offerings
Table 68. Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Biogen Inc. Key News & Latest Developments
Table 70. Merck KGaA Company Summary
Table 71. Merck KGaA Autoimmune Disorder Drug Delivery Device Product Offerings
Table 72. Merck KGaA Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Merck KGaA Key News & Latest Developments
Table 74. Bayer AG Company Summary
Table 75. Bayer AG Autoimmune Disorder Drug Delivery Device Product Offerings
Table 76. Bayer AG Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Bayer AG Key News & Latest Developments
Table 78. Johnson & Johnson Services Inc. Company Summary
Table 79. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Product Offerings
Table 80. Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Johnson & Johnson Services Inc. Key News & Latest Developments
Table 82. Teva Pharmaceutical Industries Ltd. Company Summary
Table 83. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Product Offerings
Table 84. Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Teva Pharmaceutical Industries Ltd. Key News & Latest Developments
Table 86. Eli Lily and Company Company Summary
Table 87. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Product Offerings
Table 88. Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Eli Lily and Company Key News & Latest Developments
Table 90. Sanofi S.A. Company Summary
Table 91. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Product Offerings
Table 92. Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Sanofi S.A. Key News & Latest Developments
Table 94. Takeda Pharmaceutical Company Limited Company Summary
Table 95. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Product Offerings
Table 96. Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Takeda Pharmaceutical Company Limited Key News & Latest Developments
Table 98. Autoimmune Disorder Drug Delivery Device Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Autoimmune Disorder Drug Delivery Device Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Autoimmune Disorder Drug Delivery Device Production by Region, 2018-2023 (K Units)
Table 101. Global Autoimmune Disorder Drug Delivery Device Production by Region, 2024-2030 (K Units)
Table 102. Autoimmune Disorder Drug Delivery Device Market Opportunities & Trends in Global Market
Table 103. Autoimmune Disorder Drug Delivery Device Market Drivers in Global Market
Table 104. Autoimmune Disorder Drug Delivery Device Market Restraints in Global Market
Table 105. Autoimmune Disorder Drug Delivery Device Raw Materials
Table 106. Autoimmune Disorder Drug Delivery Device Raw Materials Suppliers in Global Market
Table 107. Typical Autoimmune Disorder Drug Delivery Device Downstream
Table 108. Autoimmune Disorder Drug Delivery Device Downstream Clients in Global Market
Table 109. Autoimmune Disorder Drug Delivery Device Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Autoimmune Disorder Drug Delivery Device Segment by Type in 2022
Figure 2. Autoimmune Disorder Drug Delivery Device Segment by Application in 2022
Figure 3. Global Autoimmune Disorder Drug Delivery Device Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Autoimmune Disorder Drug Delivery Device Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Autoimmune Disorder Drug Delivery Device Revenue, 2018-2030 (US$, Mn)
Figure 7. Autoimmune Disorder Drug Delivery Device Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Autoimmune Disorder Drug Delivery Device Revenue in 2022
Figure 9. By Type - Global Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 11. By Type - Global Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 12. By Type - Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 15. By Application - Global Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 16. By Application - Global Autoimmune Disorder Drug Delivery Device Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 20. By Region - Global Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 21. By Country - North America Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 22. By Country - North America Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 23. US Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 28. Germany Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 29. France Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 37. China Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 41. India Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 43. By Country - South America Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 44. Brazil Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Autoimmune Disorder Drug Delivery Device Sales Market Share, 2018-2030
Figure 48. Turkey Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Autoimmune Disorder Drug Delivery Device Revenue, (US$, Mn), 2018-2030
Figure 52. Global Autoimmune Disorder Drug Delivery Device Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Autoimmune Disorder Drug Delivery Device by Region, 2022 VS 2030
Figure 54. Autoimmune Disorder Drug Delivery Device Industry Value Chain
Figure 55. Marketing Channels
